Join the launch webinar: Advancing Aging in Place of Choice
New Resource: DECODE CRS: Accelerating safer, scalable immunotherapy
New from the AMA: The physicians role in the AI era
NEW RESOURCE: Digital measures set for common mental health disorders
Navigating global pathways to scale digital health technologies (DHTs) is complex. These resources are designed to help you with actionable insights to understand and compare regulatory environments across Asia Pacific, Europe, and North America. With country-specific guides, step-by-step flowcharts, and supporting resources, you’ll be equipped to streamline your go-to-market strategies and bring your digital health innovations to patients worldwide faster and more efficiently.
Assess key global market pathways to bring your DHT through the regulatory process and into patients’ hands. Select a country below to explore further.
Don’t see your country? Partner with DiMe to add it to our database, enabling developers to enter your market and reach more patients.
Explore case studies of companies successfully navigating regulatory landscapes, offering insights into market entry strategies and effective evidence generation.
How will you use these resources in your work? Let us know here, to be featured on our social media and Resource in Action hub.
Do you have a story to share, like these companies? Email regulatory@dimesociety.org to discuss sponsoring the expansion of this collection.
DiMe’s global project, International Regulatory Pathways, builds upon the success of the Digital Health US Regulatory Pathways project by combining the expertise of global leaders from across the digital health technology (DHT) industry to foster innovation, drive progress, and harmonize regulatory efforts.
Looking to navigate AI/ML-specific regulatory pathways? This resource covers evidence requirements and market entry strategies for AI-enabled DHTs, helping you understand unique regulatory challenges, optimize evidence generation, and bring your products successfully to market.